APA

Carella A. M., Cascavilla N., Greco M. M., Melillo L., Sajeva M. R., Ladogana S., D'Arena G., Perla G. & Carotenuto M. (20020221). Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center study. : Leukemia & lymphoma.

Chicago

Carella A M, Cascavilla N, Greco M M, Melillo L, Sajeva M R, Ladogana S, D'Arena G, Perla G and Carotenuto M. 20020221. Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center study. : Leukemia & lymphoma.

Harvard

Carella A. M., Cascavilla N., Greco M. M., Melillo L., Sajeva M. R., Ladogana S., D'Arena G., Perla G. and Carotenuto M. (20020221). Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center study. : Leukemia & lymphoma.

MLA

Carella A M, Cascavilla N, Greco M M, Melillo L, Sajeva M R, Ladogana S, D'Arena G, Perla G and Carotenuto M. Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center study. : Leukemia & lymphoma. 20020221.